Cargando…
Illuminating the druggable genome through patent bioactivity data
The patent literature is a potentially valuable source of bioactivity data. In this article we describe a process to prioritise 3.7 million life science relevant patents obtained from the SureChEMBL database (https://www.surechembl.org/), according to how likely they were to contain bioactivity data...
Autores principales: | Magariños, Maria P., Gaulton, Anna, Félix, Eloy, Kiziloren, Tevfik, Arcila, Ricardo, Oprea, Tudor I., Leach, Andrew R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162037/ https://www.ncbi.nlm.nih.gov/pubmed/37151295 http://dx.doi.org/10.7717/peerj.15153 |
Ejemplares similares
-
Systematic illumination of druggable genes in cancer genomes
por: Jiang, Junjie, et al.
Publicado: (2022) -
Pharos: Collating protein information to shed light on the druggable genome
por: Nguyen, Dac-Trung, et al.
Publicado: (2017) -
Screening of cytoprotectors against methotrexate-induced cytogenotoxicity from bioactive phytochemicals
por: Gu, Shaobin, et al.
Publicado: (2016) -
Differential TAM receptor–ligand–phospholipid interactions delimit differential TAM bioactivities
por: Lew, Erin D, et al.
Publicado: (2014) -
Recent advances on natural depsidones: sources, biosynthesis, structure-activity relationship, and bioactivities
por: Khayat, Maan T., et al.
Publicado: (2023)